67-4

70/90

390DBS). Parkinsons Dis, 2019 Aug 4; 2019: 7104071. doi: 10.1155/2019/7104071. eCollec-tion 2019.＊ 52) Sekimoto S, Oyama G, Hatano T, Sasaki F, Nakamura R, Jo T, Shimo Y, Hattori N: A Randomized Crossover Pilot Study of Tele-medicine Delivered via iPads in Parkinson’s Disease. Parkinsons Dis, 2019 Jan 6; 2019: 9403295. doi: 10.1155/2019/9403295. 53) Shimada T, Hoshino Y, Tsunemi T, Hattori A, Nakagawa E, Yokoyama K, Hattori N: Neuromyelitis optica spectrum disorder after treatment with pembrolizumab. Mult Scler Relat Disord, 2019 Oct 14; 37: 101447. doi: 10. 1016/j.msard.2019.101447. 54) Shimo Y, Hatano T, Sakurai M, Sekimoto S, Marisdina S, Hattori N: Freezing of gait in Parkinson’s disease may share the mecha-nisms of dystonia. Neurol Sci, 2019 Nov 27. doi: 10.1007/s10072-019-04155-0. [Epub ahead of print] PubMed PMID: 31776866. 55) Shojima Y, Nishioka K, Watanabe M, Jo T, Tanaka K, Takashima H, Noda K, Okuma Y, Urabe T, Yokoyama K, Hattori N: Clinical Characterization of Definite Autoimmune Limbic Encephalitis: A 30-case Series. Intern Med, 2019 Dec 1; 58: 3369-3378. doi: 10.2169/internalmedicine.3029-19. 56) Someya Y, Tamura Y, Kaga H, Nojiri S, Shimada K, Daida H, Ishijima M, Kaneko K, Aoki S, Miida T, Hirayama S, Konishi S, Hattori N, Motoi Y, Naito H, Kawamori R, Watada H: Skeletal muscle function and need for long-term care of urban elderly people in Japan (the Bunkyo Health Study): a prospec-tive cohort study. BMJ Open, 2019 Sep 17; 9: e031584. doi: 10.1136/bmjopen-2019-031584. 57) Tachibana Y, Hagiwara A, Hori M, Kershaw J, Nakazawa M, Omatsu T, Kishimoto R, Yokoyama K, Hattori N, Aoki S, Higashi T, Obata T: The Utility of a Convolutional Neural Network for Generating a Myelin Volume Index Map from Rapid Simultaneous Relax-ometry Imaging. Magn Reson Med Sci, 2019 Dec 27. doi: 10.2463/mrms.mp.2019-0075. 58) Tamura K, Osada T, Ogawa A, Tanaka M, Suda A, Shimo Y, Hattori N, Kamagata K, Hori M, Aoki S, Shimizu T, Enomoto H, Hana-jima R, Ugawa Y, Konishi S: MRI-based visu-alization of rTMS-induced cortical plasticity in the primary motor cortex. PLoS One, 2019 Oct 24; 14: e0224175. doi: 10.1371/journal.pone. 0224175. 59) Tsunemi T, Perez-Rosello T, Ishiguro Y, Yoroisaka A, Jeon S, Hamada K, Rammonhan M, Wong YC, Xie Z, Akamatsu W, Mazzulli JR, Surmeier DJ, Hattori N, Krainc D: Increased Lysosomal Exocytosis Induced by Lysosomal Ca(2+) Channel Agonists Protects Human Dopaminergic Neurons from α-Synu-clein Toxicity. J Neurosci, 2019 Jul 17; 39: 5760-5772. doi: 10.1523/JNEUROSCI.3085-18. 2019. 60) Ueno Y, Tateishi Y, Doijiri R, Kuriki A, Shimizu T, Kikuno M, Shimada Y,Takekawa H, Yamaguchi E, Koga M, Kamiya Y, Ihara M, Tsujino A, Hirata K, Toyoda K, Hasegawa Y, Hattori N, Urabe T: Large aortic arch plaques correlate with CHADS(2) and CHA(2)DS(2)-VASc scores in cryptogenic stroke. Atherosclerosis, 2019 Mar 20; 284: 181- 186. doi: 10.1016/j.atherosclerosis.2019.03.009. 61) Valentine MNZ, Hashimoto K, Fukuhara T, Saiki S, Ishikawa KI, Hattori N, Carninci P: Multi-year whole-blood transcriptome data for the study of onset and progression of Parkinson’s Disease. Sci Data, 2019 Apr 5; 6: 20. doi: 10.1038/s41597-019-0022-9. 62) Vollstedt E.J, Kasten M, Klein C, Group M.G.G.P.s.D.S: Using global team science to identify genetic parkinson’s disease world-wide. Ann Neurol, 2019; 86: 153-157. 63) Yamashiro K, Kurita N, Tanaka R, Ueno Y, Miyamoto N, Hira K, Nakajima S, Urabe T, Hattori N: Adequate adherence to direct oral anticoagulant is associated with reduced ischemic stroke severity in patients with atrial fibrillation. J Stroke Cerebrovasc Dis, 2019; 28: 1773-1780. 64) Kerever A, Nagahara F, Keino-Masu K, Masu M, Toin van Kuppevelt T, Arikawa-Hi-rasawa E: Endosulfatases modify the heparan sulfate composition of fractones in the subven-tricular zone neurogenic niche. Proteogly-cans2019(Poster) Kanazawa 8.29-9.3, 2019. 65) Kato K, Suzuki Y, Kerever A, Arikawa-Hira-sawa E: Oligodendrocyte cell line culture on decellularized brain tissue: a new model to